Evoke Wealth, LLC Rapt Therapeutics, Inc. Transaction History

Evoke Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$29.5 - $39.5 $2,360 - $3,160	-80 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $2,388 - $3,157	80 New	80 $2,000
Q1 2021 May 13, 2021	SELL	$16.0 - $24.46 $4,320 - $6,604	-270 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.89 - $40.87 $1,509 - $3,882	95 Added 54.29%	270 $5,000
Q3 2020 Nov 13, 2020	BUY	$21.6 - $37.5 $3,780 - $6,562	175 New	175 $6,000

78.4M

213K

16.9K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.